In development: Guidance, quality standards and advice
Showing 391 to 393 of 393
| Title | Type | Expected publication date |
|---|---|---|
| Zolbetuximab with nab-paclitaxel and gemcitabine for untreated claudin 18.2-positive metastatic pancreatic cancer [ID6444] | Technology appraisal guidance | TBC |
| Zongertinib for treating HER2-mutated unresectable or metastatic non-small-cell lung cancer ID6573 | Technology appraisal guidance | TBC |
| Zuranolone for treating postnatal depression [ID6431] | Technology appraisal guidance | TBC |